Evidence map›Paper›PMID 41989782›Full record

ArticleJAMA network open2026

Nephrologist Affiliation With Dialysis Facilities and Patient Trajectories in End-Stage Kidney Disease.

Farbod Alinezhad, Gary J Young, Richard Hirth, Jianfei Cao, Brady Post

Abstract read
In one paragraph

Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Farbod AlinezhadDepartment of Health Sciences, Bouve College of Health Sciences, Northeastern University, Boston, Massachusetts.
Gary J YoungDepartment of Health Sciences, Bouve College of Health Sciences, Northeastern University, Boston, Massachusetts.
Richard HirthDepartment of Health Management and Policy, University of Michigan School of Public Health, Ann Arbor.
Jianfei CaoDepartment of Economics, College of Social Sciences and Humanities, Northeastern University, Boston, Massachusetts.
Brady PostDepartment of Health Sciences, Bouve College of Health Sciences, Northeastern University, Boston, Massachusetts.

Funding

AHRQ HHS K01 HS029278
6 · The paper itself

Abstract

Importance: Across the treatment modalities for end-stage kidney disease (ESKD), kidney transplantation offers the best survival and quality-of-life outcomes, yet most patients are unable to receive a transplant, making dialysis the most common long-term treatment option. Despite its advantages, home peritoneal dialysis (PD) use remains limited in the US, with financial incentives potentially contributing to this underutilization. Objective: To examine the association between nephrologist affiliation with dialysis facilities and facility characteristics, including profit status and PD service offerings, with 2 critical ESKD outcomes: PD catheter placement and kidney transplant surgery. Design, Setting, and Participants: This retrospective cohort study was conducted using claims data from Medicare beneficiaries with ESKD who initiated dialysis between 2013 and 2022, with follow-up through 24 months after dialysis initiation. Data were analyzed from January 1, 2024, to December 31, 2025. Exposure: Nephrologist affiliation with dialysis facilities, determined by whether a nephrologist submitted any outpatient claims from a Medicare-certified dialysis facility. Main Outcomes and Measures: Outcomes included PD catheter placement and kidney transplant surgery within 24 months of dialysis initiation. Adjusted 24-month cumulative incidences and risk differences were estimated using a doubly robust survival targeted maximum likelihood estimation framework. Results: Among the 28 040 beneficiaries (mean [SD] age, 70.6 [10.8] years; 56.8% male) included in this study, 24 301 (86.7%) were attributed to affiliated nephrologists. The mean (SD) follow-up time was 322 (307) days. The adjusted 24-month cumulative incidence of PD catheter placement was 9.9% for patients of affiliated nephrologists compared with 8.2% for patients of nonaffiliated nephrologists (adjusted difference, 1.7 percentage points [pp] [95% CI, 0.6-2.8 pp]; P = .01). In stratified models, the adjusted difference in PD catheter placement was larger for nephrologists affiliated with for-profit facilities (1.9 pp [95% CI, 0.8-3.0 pp]; P = .01) and for those affiliated with facilities offering PD (2.0 pp [95% CI, 0.8-3.2 pp]; P = .01). Differences in kidney transplant surgery within 24 months were small and not statistically significant. Conclusions and Relevance: In this retrospective cohort study of Medicare beneficiaries initiating dialysis, nephrologist affiliation with dialysis facilities, especially for-profit centers or centers offering PD, was associated with a higher 24-month cumulative incidence of PD catheter placement, while the cumulative incidence of kidney transplant surgery within 24 months did not differ meaningfully by affiliation. These findings underscore the potential role of economic and organizational factors in promoting PD, and they highlight the need for policy reforms that expand home-based dialysis while preserving equitable access to transplantation.

Indexed as

Ambulatory Care FacilitiesKidney Failure, ChronicNephrologistsNephrologyRenal DialysisAgedFemaleHumansKidney TransplantationMaleMedicareMiddle AgedRetrospective StudiesUnited States

Identifiers

PMID41989782
PMCPMC13087812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.